Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A developmental and epileptic encephalopathy caused by variation in the TMEM63B gene. This disorder is characterised by early-onset drug-resistant epilepsy, with moderate-to-profound intellectual disability, severe motor impairment and brain structural anomalies. Most patients present early generalised hypotonia, nystagmus and central visual impairment, severe dysphagia and haematological abnormalities.
No clinical trials have been registered for TMEM63B-related developmental and epileptic encephalopathy with anemia.
11 publications have been identified in PubMed for TMEM63B-related developmental and epileptic encephalopathy with anemia. Research spans Case Report / Case Series (36%), Basic Science / Preclinical (27%), and Review / Meta-Analysis (18%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 4 | 36% |
Data assembled from 2 of 12 sources · Last updated Sep 20, 2026, 8:44 AM UTC
Common questions about TMEM63B-related developmental and epileptic encephalopathy with anemia
Laboratory research |
3 |
27% |
Research summaries | 2 | 18% |
Other research | 1 | 9% |
Disease patterns and progression | 1 | 9% |
Calame DG (2025). [PMID: 39306721](https://pubmed.ncbi.nlm.nih.gov/39306721/). *Genet Med*. [Basic Science / Preclinical]
Weinstock N (2025). [PMID: 41224686](https://pubmed.ncbi.nlm.nih.gov/41224686/). *BMJ Case Rep*. [Case Report / Case Series]
Hierholzer A (2025). [PMID: 40026287](https://pubmed.ncbi.nlm.nih.gov/40026287/). *Am J Med Genet A*. [Review / Meta-Analysis]
Miyata Y (2025). [PMID: 39424995](https://pubmed.ncbi.nlm.nih.gov/39424995/). *Nat Struct Mol Biol*. [Basic Science / Preclinical]
Bögershausen N (2025). [PMID: 40131364](https://pubmed.ncbi.nlm.nih.gov/40131364/). *JCI Insight*. [Basic Science / Preclinical]
Chinedu O (2025). [PMID: 40086348](https://pubmed.ncbi.nlm.nih.gov/40086348/). *Transfus Apher Sci*. [Review / Meta-Analysis]
Bahr TM (2024). [PMID: 38784990](https://pubmed.ncbi.nlm.nih.gov/38784990/). *Pediatrics*. [Epidemiology / Natural History]
Nabavi Nouri M (2024). [PMID: 39062615](https://pubmed.ncbi.nlm.nih.gov/39062615/). *Genes (Basel)*. [Case Report / Case Series]
Silva S (2024). [PMID: 38641466](https://pubmed.ncbi.nlm.nih.gov/38641466/). *Brain Dev*. [Case Report / Case Series]
Bandara P (2024). [PMID: 39350204](https://pubmed.ncbi.nlm.nih.gov/39350204/). *BMC Pediatr*. [Case Report / Case Series]